Molecular 'foreman' discovered for brain wiring

Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning. Malfunctioning of the connection-remodeling machinery that they identified may also play a role in mental retardation, schizophrenia, and drug addiction. Thus, said the researchers, knowledge of the machinery could lead to insights into those disorders.

Peter Penzes and colleagues published their findings in the November 21, 2007, issue of the journal Neuron, published by Cell Press.

In their experiments, the researchers sought to understand the biological machinery controlling the enlargement of mushroom-like structures called dendritic spines on neurons. Such spines are the receiving stations for neurotransmitters—signaling chemicals that one neuron launches to trigger a nerve impulse in its neighbor. During learning, these spines strengthen signaling between neurons during the process of laying down memory pathways in the brain.

Spine structure can also be involved in neurological disorders. Researchers have found abnormal dendritic spines in certain types of mental retardation, including autism spectrum disorders, as well as schizophrenia and drug addiction.

Specifically, Penzes and colleagues sought to discover whether a molecule called kalirin-7 plays a role in spine enlargement in mature neurons when they undergo a learning-related strengthening called long-term potentiation (LTP).

The researchers theorized that kalirin-7 might be a key regulator of spine development because it is found in high concentration in the spines of mature neurons. Also, kalirin-7 was known to play a role in the remodeling of the structural beams and studs of the cell, called the cytoskeleton.

The researchers’ experiments with cultured neurons revealed that activation of neurons during LTP does indeed trigger kalirin-7 to turn on the machinery for remodeling spines, causing spines to become enlarged.

What’s more, the researchers found that kalirin-7 also regulates the other major process necessary for strengthening neuronal signaling connections. Kalirin-7 controls the number of neurotransmitter-receiving stations, called receptors, that festoon the surface of dendritic spines. The number of these receptors determines the strength of signaling connections between neurons.

The researchers concluded that their findings “strongly suggest that kalirin-7 may be an important regulator of the experience-dependent modifications of forebrain circuits during postnatal development and may play an important role in learning and memory.”

They also pointed out that altered spine structures “have been associated with mental retardation, neuropsychiatric disorders, and drug addiction. Specifically, aberrant spine morphology in forebrain occurs in many types of mental retardation, including fragile-X and autism spectrum disorders.” Similarly, they noted, studies of schizophrenics have also revealed such alteration of dendritic spines, as well as evidence of defects in the kalirin-7 pathway.

“Therefore, our results may suggest potential strategies for treatments of these neurodevelopmental and psychiatric diseases,” they wrote.

Source: Cell Press

Related stories:

Researchers propose minocycline as a promising drug for patients with Fragile X syndrome
A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
Cocaine-induced brain plasticity may protect the addicted brain
A new study has unraveled some of the mysteries of the cocaine-addicted brain and may pave the way for the design of more effective treatments for drug addiction. The research, published by Cell Press in the August 28 issue of the journal Neuron, identifies specific brain mechanisms that underlie addiction-related structural changes in the brain and provides surprising insight into how these changes may actually defend the brain during excessive drug use.
Location, location, location
Neuroscientists at Georgetown University Medical Center have solved a mystery that lies at the heart of human learning, and they say the solution may help explain some forms of mental retardation as well as provide clues to overall brain functioning.
Stopping a receptor called 'nogo' boosts the synapses
New findings about a protein called the nogo receptor are offering fresh ways to think about keeping the brain sharp.
Short-term stress can affect learning and memory
Short-term stress lasting as little as a few hours can impair brain-cell communication in areas associated with learning and memory, University of California, Irvine researchers have found.
Brain chemistry ties anxiety and alcoholism
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.
Genetic tags reveal secrets of memories' staying power in mice
A better understanding of how memory works is emerging from a newfound ability to link a learning experience in a mouse to consequent changes in the inner workings of its neurons. Researchers, supported in part by the National Institutes of Health's National Institute of Mental Health (NIMH), have developed a way to pinpoint the specific cellular components that sustain a specific memory in genetically-engineered mice.

News discussion:

Medicine & Health news